Advisornet Financial’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-350
Closed -$17K 2195
2021
Q4
$17K Hold
350
﹤0.01% 1334
2021
Q3
$19K Hold
350
﹤0.01% 1268
2021
Q2
$19K Hold
350
﹤0.01% 1248
2021
Q1
$20K Hold
350
﹤0.01% 1197
2020
Q4
$15K Hold
350
﹤0.01% 1200
2020
Q3
$14K Hold
350
﹤0.01% 1194
2020
Q2
$15K Hold
350
﹤0.01% 1194
2020
Q1
$12K Sell
350
-125
-26% -$4.51K ﹤0.01% 1230
2019
Q4
$20K Sell
475
-3,875
-89% -$163K ﹤0.01% 1189
2019
Q3
$199K Buy
4,350
+4,000
+1,143% +$174K 0.02% 509
2019
Q2
$15K Sell
350
-200
-36% -$8.44K ﹤0.01% 1136
2019
Q1
$24K Hold
550
﹤0.01% 949
2018
Q4
$26K Hold
550
﹤0.01% 865
2018
Q3
$41K Buy
550
+200
+57% +$13.8K 0.01% 786
2018
Q2
$19K Buy
+350
New +$16.2K ﹤0.01% 961

Other funds holding SRDX

Advisornet Financial's SRDX Position: Q1 2022 in Review

Advisornet Financial sold out of Surmodics (SRDX) in Q1 2022, closing a stake of 350 shares — an estimated $17K sold.

Advisornet Financial first reported a position in SRDX in Q2 2018 and held it in 15 quarters. The position peaked at $199K in Q3 2019. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2022.

  • Advisornet Financial reported no remaining Surmodics position as of Q1 2022 after selling out during the quarter.
  • Advisornet Financial sold 350 Surmodics shares in Q1 2022, an estimated $17K.
  • Advisornet Financial first reported a position in Surmodics in Q2 2018 and held it in 15 quarters.
  • Advisornet Financial's Surmodics position peaked at $199K in Q3 2019.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2022.

Based on Advisornet Financial's 13F filing for Q1 2022, filed 14 Apr 2022.